Open access · CC-BY
via OpenAlex
Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging
Olga V. Leontieva, Geraldine Paszkiewicz, Mikhail V. Blagosklonny
Aging · 2012 · ▲ 52 citations
Deregulated nutrient-sensing
Intermittent fasting
Rapamycin / mTOR inhibition
Cell culture / in vitro
Human
Mouse
Abstract
Males, who are bigger and stronger than females, live shorter in most species from flies to mammals including humans. Cellular mass growth is driven in part by mTOR(definition) (Target of Rapamycin(definition)). When developmental growth is completed, then, instead of growth, mTOR drives aging, manifested by increased cellular functions, such as hyper-secretion by fibroblasts, thus altering homeostasis, leading to age-related diseases and death. We hypothesize that MTOR activity is elevated in male mice compared with females. Noteworthy, 6 months old males were 28 % heavier than females. Also levels of phosphorylated S6 (pS6) and phospho-AKT (p-AKT, Ser 473), markers of the mTOR activity, were higher in male organs tested. Levels of pS6 were highly variable among mice and correlated with body weight and p-AKT. With age, the difference between levels of pS6 between sexes tended to minimize, albeit males still had hyperactive mTOR. Unlike fasting, the intraperitoneal (i.p.) administration of rapamycin eliminated pS6 in all organs of all females measured by immunoblotting and immunohistochemistry without affecting p-AKT and blood insulin. Although i.p. rapamycin dramatically decreased levels of pS6 in males too, it was still detectable by immunoblotting upon longer exposure. Our study demonstrated that both tissue p-AKT and pS6 were higher in young male mice and were associated with increased body weight and insulin. These data can explain bigger body size and faster aging in males. Our data suggest higher efficacy of rapamycin compared to fasting. Higher sensitivity of females to rapamycin may explain more pronounced life extension by rapamycin observed in females compared to males in several studies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/aging.100528
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Leontieva, O.V., Paszkiewicz, G., & Blagosklonny, M.V. (2012). Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging. <em>Aging</em>. https://doi.org/10.18632/aging.100528
Vancouver
Leontieva OV, Paszkiewicz G, Blagosklonny MV. Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging. Aging. 2012. doi:10.18632/aging.100528.
BibTeX
@article{olga2012Mechan,
title = {Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging},
author = {Olga V. Leontieva and Geraldine Paszkiewicz and Mikhail V. Blagosklonny},
journal = {Aging},
year = {2012},
doi = {10.18632/aging.100528},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2020
Preprint · CC-BY
Epigenetic clock and DNA methylation analysis of porcine models of aging and obesity
biorxiv 2025
Preprint · CC-BY
Exploring the role of transposable elements to sex gap in longevity in Drosophila species
Innovation in Aging 2024
Open access · CC-BY
SEX AS A BIOLOGICAL VARIABLE IN CARDIAC AGING: CORRELATIONS AMONG ECHOCARDIOGRAM, FRAILTY, AND ANESTHESIA RECOVERY
Anthropological Review 2015
Open access · CC-BY
Longitudinal and cross-sectional changes with age in selected anthropometric and physiological traits in hospitalized adults: an insight from the Polish Longitudinal Study of Aging (PLSA)
Scientifica 2013
Open access · CC-BY
mTOR Inhibition: From Aging to Autism and Beyond
BMC Geriatrics 2018
Open access · CC-BY